These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19452774)

  • 1. [Aldosterone block in proteinuria].
    Kooter AJ; Smulders YM
    Ned Tijdschr Geneeskd; 2009 Apr; 153(15):710-4. PubMed ID: 19452774
    [No Abstract]   [Full Text] [Related]  

  • 2. Aldosterone and progression of kidney disease.
    Cortinovis M; Perico N; Cattaneo D; Remuzzi G
    Ther Adv Cardiovasc Dis; 2009 Apr; 3(2):133-43. PubMed ID: 19171691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
    Hirsch S
    Compr Ther; 2009; 35(2):91-5. PubMed ID: 19618757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone and progression of renal disease.
    Wenzel U
    Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):44-50. PubMed ID: 18090669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological mechanism of modern diuretics. Aldosterone antagonists].
    Kinouchi T; Shimizu N
    Nihon Rinsho; 1984 Sep; 42(9):1994-2000. PubMed ID: 6097705
    [No Abstract]   [Full Text] [Related]  

  • 6. Aldosterone in renal disease.
    Ibrahim HN; Hostetter TH
    Curr Opin Nephrol Hypertens; 2003 Mar; 12(2):159-64. PubMed ID: 12589176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone blockade in diabetic nephropathy: relative risks and potential promise.
    Rubin MF; Townsend RR
    J Am Soc Nephrol; 2009 Dec; 20(12):2487-9. PubMed ID: 19875814
    [No Abstract]   [Full Text] [Related]  

  • 8. [Old and new drugs to block aldosterone and ameliorate cardiovascular disease].
    Fiebeler A; Luft FC
    Dtsch Med Wochenschr; 2004 Nov; 129(46):2491-6. PubMed ID: 15536584
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pathophysiology of kidney disease progression].
    Krummel T; Bazin D; Hannedouche T
    Presse Med; 2007 Dec; 36(12 Pt 2):1835-41. PubMed ID: 17656061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hazards of dual renin-angiotensin blockade in chronic kidney disease.
    Ku E; Park J; Vidhun J; Campese V
    Arch Intern Med; 2009 Jun; 169(11):1015-8. PubMed ID: 19506167
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of disease: The role of aldosterone in kidney damage and clinical benefits of its blockade.
    Del Vecchio L; Procaccio M; Viganò S; Cusi D
    Nat Clin Pract Nephrol; 2007 Jan; 3(1):42-9. PubMed ID: 17183261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone synthase inhibitors: pharmacological and clinical aspects.
    Jansen PM; van den Meiracker AH; Jan Danser AH
    Curr Opin Investig Drugs; 2009 Apr; 10(4):319-26. PubMed ID: 19337952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G
    J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker].
    Belenkov IuN; Mareev VIu; Skvortsov AA
    Ter Arkh; 2008; 80(9):5-12. PubMed ID: 19555028
    [No Abstract]   [Full Text] [Related]  

  • 15. Extracellular volume and aldosterone interaction in chronic kidney disease.
    Klemmer PJ; Bomback AS
    Blood Purif; 2009; 27(1):92-8. PubMed ID: 19169025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the renin-angiotensin system blockage on the plasma adiponectin levels and insulin sensitivity in patients with chronic kidney disease.
    Yazici M; Sonmez A; Kutlu M; Yilmaz MI
    Nephrol Dial Transplant; 2009 Aug; 24(8):2603-4; author reply 2604-5. PubMed ID: 19465556
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of aldosterone blockade in end-stage renal disease.
    Pitt B; Saran R
    Cardiology; 2009; 114(1):30-1. PubMed ID: 19342856
    [No Abstract]   [Full Text] [Related]  

  • 18. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aldosterone and kidney damage: clinical implications].
    Del Vecchio L; Sitia S
    G Ital Nefrol; 2009; 26(3):347-54. PubMed ID: 19554532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD.
    Agarwal R
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1523-8. PubMed ID: 19478099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.